Xavier University of Louisiana

États‑Unis d’Amérique


 
Quantité totale PI 43
Rang # Quantité totale PI 32 313
Note d'activité PI 2,1/5.0    19
Rang # Activité PI 43 386
Classe Nice dominante Vêtements; chaussures; chapellerie

Brevets

Marques

16 5
1 0
21 0
0
 
Dernier brevet 2024 - S6k1 protein kinase inhibitors a...
Premier brevet 2004 - Bisbenzamidines for the treatmen...
Dernière marque 2022 - XULA
Première marque 2021 - XULA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention S6k1 protein kinase inhibitors as cancer therapeutics. The present disclosure relates to compoun...
Invention Protein kinase inhibitors. The present disclosure relates to compounds that act as protein kinas...
Invention Phenyl unsaturated ketones as human factor xiiia inhibitors for treatment of thromboembolic disea...
2022 P/S License plate frames Key chains; lapel pins Decals, stickers, pens, writing paper pads; blank wri...
2021 Invention S6k1 protein kinase inhibitors as cancer therapeutics. The present disclosure relates to compound...
P/S Jewelry and watches Decals, stickers, office supplies, namely, pens, paper folders, and stationer...
P/S decals; stickers; office supplies, namely, pens, office binders, stationery, blank writing journa...
P/S Jewelry, watches Clothing of all types for infants, children, women, and men, namely, knit face m...
P/S Decals, stickers, office supplies, namely, pens, ring binders, loose-leaf binders, three-ring bin...
2020 Invention Methods of solvent removal at ambient temperatures—cryovap. Disclosed are methods of solvent remo...
Invention Methods of solvent removal at ambient temperatures - cryovap. Disclosed are methods of solvent re...
Invention Protein kinase inhibitors and use thereof for treatment of neurodegenerative diseases. The prese...
Invention Protein kinase inhibitors and use thereof for treatment of neimodegenerative diseases. The presen...
2019 Invention Protein kinase inhibitors. The present disclosure relates to compounds that act as protein kinase...
Invention Estrogen receptor targeting antagonists. The present disclosure relates to compounds that act as...
Invention Estrogen receptor targeting antagonists. The present disclosure relates to compounds that act as ...
2017 Invention Boronic derivatives of hydroxamates as anticancer agents. The present disclosure relates to boron...
Invention Boronic derivatives hydroxamates as anticancer agents. The present disclosure relates to boronic ...
Invention Inhibitors of androgen receptor signaling. The present disclosure relates to androgen receptor si...
Invention 2-hydroxyisophthalic acid and its derivatives: methods of making and applications. Substituted de...
Invention Selective estrogen receptor down-regulators (serds). The present disclosure relates to orally bi...
Invention Selective estrogen receptor down-regulators (serds). The present disclosure relates to orally bio...
2015 Invention Inhibition of hsv-1-associated corneal neovascularization using inhibitors of cyclin-dependent ki...
Invention Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug...
Invention Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer. Combretastatins...
Invention Daidzein analogs as treatment for cancer. Provided are compositions for treatment of cancers, inc...
2014 Invention Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells. Disclosed are d...
2013 Invention Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease...
Invention Method for treating diabetic retinopathy. Compositions useful for treatment of retinal pathologie...
Invention Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer. The present...
2012 Invention Inhibiting hepatitis c viral replication with sirna combinations. Compositions are disclosed of ...
2011 Invention A method of inhibiting angiogenesis. A method of inhibiting angiogenesis in mammals using introdu...
Invention Novel daidzein analogs as treatment for cancer. Provided are compositions for treatment of cancer...
Invention Bisbenzamidines for the treatment of pneumonia. Pneumocystis pneumonia, and a method of treating ...
2010 Invention Method of inhibiting angiogenesis. A method of inhibiting angiogenesis in mammals using introduc...
Invention Compounds, their syntheses, compositions, and methods to treat cancer. Compounds and their synthe...
2009 Invention Bisbenzimidazoles as antimalarial agents. The present invention relates to antimalarial agents. ...
Invention Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates,...
2008 Invention Controlled release multiple layer coatings. A process for making controlled release pharmaceutica...
2007 Invention Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis. Disclo...
Invention Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis. Disclos...
Invention An improved method of micro-encapsulation. A method of preparing micro-capsules. The active ingre...
Invention Controlled release multiple layer coatings. A process for making controlled release pharmaceutic...
2005 Invention Methods and compositons for treating cancer. Pharmaceutical compositions, kits and methods useful...
2004 Invention Bisbenzamidines for the treatment of pneumonia. A method of combating infectious agents, such...